These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21668921)

  • 21. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 22. Progression of mild cognitive impairment to Alzheimer's disease: improved diagnostic value of the combined use of N200 latency and beta-amyloid(1-42) levels.
    Papaliagkas VT; Anogianakis G; Tsolaki MN; Koliakos G; Kimiskidis VK
    Dement Geriatr Cogn Disord; 2009; 28(1):30-5. PubMed ID: 19628938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.
    Stomrud E; Hansson O; Blennow K; Minthon L; Londos E
    Dement Geriatr Cogn Disord; 2007; 24(2):118-24. PubMed ID: 17622715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
    Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
    Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New developments in the treatment of Alzheimer's disease.
    J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644
    [No Abstract]   [Full Text] [Related]  

  • 26. Testing the mettle of PBT2 for Alzheimer's disease.
    Relkin NR
    Lancet Neurol; 2008 Sep; 7(9):762-3. PubMed ID: 18672401
    [No Abstract]   [Full Text] [Related]  

  • 27. Tapping into the biology of Alzheimer disease.
    Knopman DS
    Neurology; 2011 Feb; 76(6):496-7. PubMed ID: 21228299
    [No Abstract]   [Full Text] [Related]  

  • 28. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.
    Winblad B; Grossberg G; Frölich L; Farlow M; Zechner S; Nagel J; Lane R
    Neurology; 2007 Jul; 69(4 Suppl 1):S14-22. PubMed ID: 17646619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amyloid beta peptide].
    Kowa H; Iwatsubo T
    Nihon Rinsho; 2004 Nov; 62 Suppl 11():307-9. PubMed ID: 15628403
    [No Abstract]   [Full Text] [Related]  

  • 30. Years of severe and isolated amnesia can precede the development of dementia in early-onset Alzheimer's disease.
    Stokholm J; Jakobsen O; Czarna JM; Mortensen HV; Waldemar G
    Neurocase; 2005 Feb; 11(1):48-55. PubMed ID: 15804924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.
    Relkin NR; Szabo P; Adamiak B; Burgut T; Monthe C; Lent RW; Younkin S; Younkin L; Schiff R; Weksler ME
    Neurobiol Aging; 2009 Nov; 30(11):1728-36. PubMed ID: 18294736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
    Höglund K; Hansson O; Buchhave P; Zetterberg H; Lewczuk P; Londos E; Blennow K; Minthon L; Wiltfang J
    Neurodegener Dis; 2008; 5(5):268-76. PubMed ID: 18309230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective reduction of amyloid beta42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation.
    Mollenhauer B; Bibl M; Esselmann H; Steinacker P; Trenkwalder C; Brechlin P; Wiltfang J; Otto M
    J Neurol Neurosurg Psychiatry; 2006 Oct; 77(10):1201-3. PubMed ID: 16549413
    [No Abstract]   [Full Text] [Related]  

  • 34. Bapineuzumab in Alzheimer's disease: where now?
    Wilcock GK
    Lancet Neurol; 2010 Feb; 9(2):134-6. PubMed ID: 20129159
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of intraarticular infliximab administration in patients with recurrent gonarthritis: comment on the article by van der Bijl et al.
    Drosos AA
    Arthritis Care Res (Hoboken); 2010 Feb; 62(2):291; author reply 291-2. PubMed ID: 20191533
    [No Abstract]   [Full Text] [Related]  

  • 36. [Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23].
    Irie K; Murakami K; Masuda Y; Murata N; Noda Y; Hatsuta H; Murayama S; Shimizu T; Horikoshi Y; Kinoshita N; Shirasawa T
    Rinsho Shinkeigaku; 2011 Nov; 51(11):890-1. PubMed ID: 22277406
    [No Abstract]   [Full Text] [Related]  

  • 37. Peering inside Alzheimer's brains.
    Sinha G
    Nat Biotechnol; 2011 May; 29(5):384-7. PubMed ID: 21552232
    [No Abstract]   [Full Text] [Related]  

  • 38. New US guidelines for Alzheimer's disease released.
    Larkin M
    Lancet; 2001 May; 357(9267):1505. PubMed ID: 11377609
    [No Abstract]   [Full Text] [Related]  

  • 39. Intrathecal Immunoselective Nanopheresis for Alzheimer's Disease: What and How? Why and When?
    Menendez-Gonzalez M
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39408961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease: future treatments.
    Morley JE
    J Am Med Dir Assoc; 2011 Jan; 12(1):1-7. PubMed ID: 21243833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.